Molecular Hydrogen Attenuated N-methyl-N-Nitrosourea Induced Corneal Endothelial Injury by Upregulating Anti-Apoptotic Pathway.
Li R, Qu Y, Li X, Tao Y, Yang Q, Wang J, Diao Y, Li Q, Fang Y, Huang Y, Wang L · Investigative ophthalmology & visual science · 2021
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
The publication “Molecular Hydrogen Attenuated N-methyl-N-Nitrosourea Induced Corneal Endothelial Injury by Upregulating Anti-Apoptotic Pathway.” is organized in H2HUBB under the research focus hydrogen-rich saline blood pressure study 2021. The publication is cited as Li R, Qu Y, Li X, Tao Y, Yang Q, Wang J, Diao Y, Li Q, Fang Y, Huang Y, Wang L, Investigative ophthalmology & visual science, 2021. This in vitro or cellular study examined Molecular Hydrogen Attenuated N-methyl-N-Nitrosourea Induced Corneal Endothelial Injury by Upregulating Anti-Apoptotic Pathway. The abstract describes Endothelial cell model; hydrogen delivered as hydrogen-rich saline; reported duration 14 days. The abstract reports: This study suggests that topical application of H2 could protect CECs against corneal damage factors through anti-apoptotic effect, reduce the incidence and severity of…. This is an automated editorial draft based on the abstract and requires source review before publication.
Hydrogen-rich saline blood pressure study 2021 overview
Previous work by our group has demonstrated the value of N-methyl-N-nitrosourea (MNU)-induced corneal endothelial decompensation in animal models. The aim of this study was… Laboratory and cellular research can clarify mechanisms, but it does not establish clinical benefit or reproduce the complexity of a living human system.
Study design and hydrogen intervention
Publication type: In vitro or cellular study. Evidence type: Laboratory or cellular evidence. Research model or population: Endothelial cell model. Blinding: Unknown. Control status: Unknown.
Delivery method: Hydrogen-rich saline. Treatment duration: 14 days.
Reported findings and scientific interpretation
For this hydrogen-rich saline blood pressure study 2021, the study record reports the following: The abstract reports: This study suggests that topical application of H2 could protect CECs against corneal damage factors through anti-apoptotic effect, reduce the incidence and severity of…
These findings should be interpreted as one piece of evidence rather than as a stand-alone medical conclusion. Results can be influenced by the research model, study design, treatment protocol, sample size, outcome selection, statistical methods, and whether the findings have been independently reproduced.
How this research record was prepared
H2HUBB organizes bibliographic details, study design information, intervention data, outcomes, limitations, and safety notes from the available scientific source. Automated classification supports database organization, but it does not replace critical reading of the complete paper. Source identifiers, evidence labels, and delivery-method fields are retained so readers can verify the record and compare it with related publications. A missing field means the information was unavailable or not reported in the structured source; it should not be treated as a negative finding.
Limitations, safety, and original source
Limitations: Laboratory findings may not translate directly to living organisms or clinical outcomes.
The intervention or follow-up period appears relatively short.
Safety: The abstract did not provide detailed safety or adverse-event information.
This H2HUBB page is an educational research record, not medical advice. Review the original scientific source for the complete methods and results. Continue exploring the H2HUBB Molecular Hydrogen Research Library to compare evidence types, delivery methods, and related topics.